U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT06862557) titled 'Pulsed Electromagnetic Field Treatment With Alzheimer's Disease Patients' on March 02.
Brief Summary: An open label pilot study in mild to moderate AD patients to assess the effects of treatment with ECHS AD pulsed electromagnetic treatment device on disease progression. Enrolled patients will receive active devices. They will treat themselves at home three times a day for 15 minutes over 120 days. Primary end points are the The Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Mini-Mental State Exam. Participants will be followed-up for 9 months post-treatment.
Study Start Date: March 15
Study Type: INTERVENTIONAL
...